Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies?

Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease

(2011) Ann K Daly et al.   Expert Review of Gastroenterology & Hepatology

A Role for Low Hepatic Copper Concentrations in Nonalcoholic Fatty Liver Disease

(2010) Elmar Aigner et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

(2010) P. Loria et al.   DIGESTIVE AND LIVER DISEASE

The Natural History of Non-Alcoholic Fatty Liver Disease

(2010) Stephen Caldwell et al.   DIGESTIVE DISEASES

Trunk Fat as a Determinant of Liver Disease

(2010) Jacquelyn J. Maher   GASTROENTEROLOGY

Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency

(2010) Melanie D. Spencer et al.   GASTROENTEROLOGY

Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues

(2010) Vlad Ratziu et al.   HEPATOLOGY

Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease

(2010) Nathan A. Johnson et al.   HEPATOLOGY

High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial

(2010) Ulrich F. H. Leuschner et al.   HEPATOLOGY

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

(2010) Giovanni Musso et al.   HEPATOLOGY

Novel Evidence for Chronic Exposure to Endotoxin in Human Nonalcoholic Steatohepatitis

(2010) Froukje J. Verdam et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Hepatocellular ballooning in NASH

(2010) Stephen Caldwell et al.   JOURNAL OF HEPATOLOGY

A position statement on NAFLD/NASH based on the EASL 2009 special conference

(2010) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis

(2010) Detlef Schuppan et al.   LIVER INTERNATIONAL

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease

(2009) E. VILAR GOMEZ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 Rats

(2009) Yongzhong Wei et al.   AMERICAN JOURNAL OF PATHOLOGY

Treatment of nonalcoholic fatty liver disease in children: TONIC trial design

(2009) Joel E. Lavine et al.   Contemporary Clinical Trials

Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation

(2009) Masato Yoneda et al.   DIGESTIVE DISEASES AND SCIENCES

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

(2009) Kittichai Promrat et al.   HEPATOLOGY

Fructose takes a toll

(2009) Miriam B. Vos et al.   HEPATOLOGY

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis

(2009) Amalia Gastaldelli et al.   HEPATOLOGY

Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial

(2009) Vlad Ratziu et al.   HEPATOLOGY

Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial

(2009) Manal F. Abdelmalek et al.   HEPATOLOGY

CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis

(2009) Mirko Moreno Zaldivar et al.   HEPATOLOGY

A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis

(2009) Austin Nelson et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study

(2009) Youming Li et al.   JOURNAL OF HEPATOLOGY

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

(2009) Curtis K. Argo et al.   JOURNAL OF HEPATOLOGY

Endocrine and liver interaction: the role of endocrine pathways in NASH

(2009) Paola Loria et al.   Nature Reviews Gastroenterology & Hepatology

Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis

(2009) Eugen Florin Georgescu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Metformin use in children with nonalcoholic fatty liver disease: An open-label, 24-month, observational pilot study

(2008) V NOBILI et al.   CLINICAL THERAPEUTICS

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

(2008) Vlad Ratziu et al.   GASTROENTEROLOGY

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

(2008) Guruprasad P. Aithal et al.   GASTROENTEROLOGY

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial

(2008) Valerio Nobili et al.   HEPATOLOGY

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

(2008) Stephen A. Harrison et al.   HEPATOLOGY

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

(2008) Kristiaan Wouters et al.   HEPATOLOGY